CONSHOHOCKEN, Pa., January 08, 2025--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025, prior to ...

Cencora (COR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Investors need to ...

In a report released on January 5, Steven Valiquette from Mizuho Securities maintained a Buy rating on Cencora (COR – Research Report). The company’s shares closed yesterday at $228.88.

Cencora, Inc. has a fifty-two week low of $214.77 and a fifty-two week high of $253.27. Cencora Increases Dividend The business also recently announced a quarterly dividend, which was paid on ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the completion of its previously announced acquisition of Retina Consultants of America (“RCA”), a leading ...

Cencora announced the completion of its acquisition of Retina Consultants of America, a management services organization of retina specialists. Cencora has acquired an interest in RCA of ...

Cencora (NYSE:COR) raised its 2025 adjusted EPS forecast to reflect its takeover of Retina Consultants of America, or RCA, and momentum in its U.S. healthcare solutions unit. The healthcare ...